한글목차

급성 허혈성 뇌졸중 진단의 동향과 예측

세계의 급성 허혈성 뇌졸중 진단 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 7.2%를 나타낼 전망이며 2030년에는 30억 달러에 달할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 급성 뇌졸중 환자 증가, 뇌졸중에 대한 인식 증가, 진단 및 수술 장비의 기술 혁신입니다. 세계의 급성 허혈성 뇌졸중 진단 시장의 미래는 컴퓨터 단층 촬영, 자기 공명 영상, 경동맥 초음파, 뇌 혈관 촬영, 심전도, 심 초음파 검사의 각 시장에서의 기회에 의해 유망시되고 있습니다.

급성 허혈성 뇌졸중 진단 시장 인사이트

Lucintel은 예측 기간 동안 컴퓨터 단층 촬영이 최대 부문로 계속 될 것으로 예측됩니다.

북미는 정부 이니셔티브 증가, 지속적인 기술 진보, 허혈성 뇌졸중 관련 제품에 대한 수요가 증가함에 따라 예측 기간 동안 최대 지역이 될 것입니다.

이 보고서는 다음 11가지 주요 질문에 답변합니다.

• Q.1. 시장 부문 중 가장 유망하고 고성장하는 기회는 무엇인가?
• Q.2. 어떤 부문이 더 빠른 속도로 성장하는지, 그리고 그 이유는?
• Q.3. 앞으로 성장이 가속될 것으로 보이는 지역과 그 이유는?
• Q.4. 시장 역학에 영향을 미치는 주요 요인은? 시장의 주요 과제와 비즈니스 리스크는?
• Q.5. 이 시장에서의 비즈니스 리스크와 경쟁 위협은?
• Q.6. 이 시장에서의 새로운 동향과 그 이유는?
• Q.7. 시장에서 고객 수요 변화에는 어떤 것이 있는가?
• Q.8. 이 시장에서의 새로운 개발과 그 개발을 리드하고 있는 기업은?
• Q.9. 이 시장에서 주요 기업은? 주요 기업은 사업 성장을 위해 어떤 전략적 노력을 추진하고 있는가?
• Q.10. 이 시장에서 경쟁 제품은 어떠한 것이며, 재료 및 제품의 대체로 인한 시장 점유율 저하의 위협은 어느 정도입니까?
• Q.11. 지난 5년 동안 어떤 M&D가 수행되었고 업계에 어떤 영향을 미쳤는가?

목차

제1장 주요 요약

제2장 세계의 급성 허혈성 뇌졸중 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 급성 허혈성 뇌졸중 진단 시장 동향(2018-2023년)과 예측(2024-2030년)
• 진단 유형별 세계의 급성 허혈성 뇌졸중 진단 시장
  • 컴퓨터 단층 촬영
  • 자기 공명 화상
  • 경동맥 초음파 검사
  • 뇌혈관 조영
  • 심전도 검사
  • 심장 초음파 검사
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 급성 허혈성 뇌졸중 진단 시장
• 북미의 급성 허혈성 뇌졸중 진단 시장
• 유럽의 급성 허혈성 뇌졸중 진단 시장
• 아시아태평양 급성 허혈성 뇌졸중 진단 시장
• 기타 지역 급성 허혈성 뇌졸중 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 진단 유형별 세계의 급성 허혈성 뇌졸중 진단 시장의 성장 기회
  • 지역별 세계의 급성 허혈성 뇌졸중 진단 시장의 성장 기회
• 세계의 급성 허혈성 뇌졸중 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 급성 허혈성 뇌졸중 진단 시장의 능력 확대
  • 세계의 급성 허혈성 뇌졸중 진단 시장에서의 합병, 인수, 합작 사업
  • 인증 및 라이센스

제7장 유력 기업의 기업 프로파일

• Fujifilm Holdings
• 삼성전자
• GE Healthcare
• Nihon Kohden
• Canon Medical Systems
• Koninklijke Philips NV
• Siemens Healthineers
• Mindray Medical International
• Nanavati Super Speciality Hospital
• Hoffmann-La Roche

영문목차

Acute Ischemic Stroke Diagnosis Trends and Forecast

The future of the global acute ischemic stroke diagnosis market looks promising with opportunities in the computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography markets. The global acute ischemic stroke diagnosis market is expected to reach an estimated $3.0 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are the growing number of acute stroke patients, rising awareness towards stroke, and technological innovations in diagnostic and surgical devices.

A more than 150-page report is developed to help in your business decisions.

Acute Ischemic Stroke Diagnosis by Segment

The study includes a forecast for the global acute ischemic stroke diagnosis by diagnostic type and region.

Acute Ischemic Stroke Diagnosis Market by Diagnostic Type [Shipment Analysis by Value from 2018 to 2030]:

• Computed Tomography
• Magnetic Resonance Imaging
• Carotid Ultrasound
• Cerebral Angiography
• Electrocardiography
• Echocardiography
• Others

Acute Ischemic Stroke Diagnosis Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acute Ischemic Stroke Diagnosis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acute ischemic stroke diagnosis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acute ischemic stroke diagnosis companies profiled in this report include-

• Fujifilm Holdings
• Samsung Electronics
• Ge Healthcare
• Nihon Kohden
• Canon Medical Systems
• Koninklijke Philips Nv
• Siemens Healthineers
• Mindray Medical International
• Nanavati Super Speciality Hospital
• Hoffmann-La Roche

Acute Ischemic Stroke Diagnosis Market Insights

Lucintel forecasts that computed tomography will remain the largest segment over the forecast period.

North America will remain the largest region over the forecast period due to increasing government initiatives, ongoing technological advancements, and rising demand for ischemic stroke-related products.

Features of the Global Acute Ischemic Stroke Diagnosis Market

Market Size Estimates: Acute ischemic stroke diagnosis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acute ischemic stroke diagnosis market size by diagnostic type, and region. in terms of value ($B).

Regional Analysis: Acute ischemic stroke diagnosis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different diagnostic type, and region.s for the acute ischemic stroke diagnosis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acute ischemic stroke diagnosis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the acute ischemic stroke diagnosis market size?

Answer: The global acute ischemic stroke diagnosis market is expected to reach an estimated $3.0 billion by 2030.

Q.2. What is the growth forecast for acute ischemic stroke diagnosis market?

Answer: The global acute ischemic stroke diagnosis market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the acute ischemic stroke diagnosis market?

Answer: The major drivers for this market are the growing number of acute stroke patients, rising awareness towards stroke, and technological innovations in diagnostic and surgical devices.

Q.4. What are the major segments for acute ischemic stroke diagnosis market?

Answer: The future of the acute ischemic stroke diagnosis market looks promising with opportunities in the computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, and echocardiography markets.

Q.5. Who are the key acute ischemic stroke diagnosis market companies?

Answer: Some of the key acute ischemic stroke diagnosis companies are as follows:

• Fujifilm Holdings
• Samsung Electronics
• GE Healthcare
• Nihon Kohden
• Canon Medical Systems
• Koninklijke Philips NV
• Siemens Healthineers
• Mindray Medical International
• Nanavati Super Speciality Hospital
• Hoffmann-La Roche

Q.6. Which acute ischemic stroke diagnosis market segment will be the largest in future?

Answer: Lucintel forecasts that computed tomography will remain the largest segment over the forecast period.

Q.7. In acute ischemic stroke diagnosis market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing government initiatives, ongoing technological advancements, and rising demand for ischemic stroke-related products.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acute ischemic stroke diagnosis market by diagnostic type (computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acute Ischemic Stroke Diagnosis Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acute Ischemic Stroke Diagnosis Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acute Ischemic Stroke Diagnosis Market by Diagnostic Type
  • 3.3.1: Computed Tomography
  • 3.3.2: Magnetic Resonance Imaging
  • 3.3.3: Carotid Ultrasound
  • 3.3.4: Cerebral Angiography
  • 3.3.5: Electrocardiography
  • 3.3.6: Echocardiography
  • 3.3.7: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acute Ischemic Stroke Diagnosis Market by Region
• 4.2: North American Acute Ischemic Stroke Diagnosis Market
• 4.3: European Acute Ischemic Stroke Diagnosis Market
  • 4.3.1: European Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others
• 4.4: APAC Acute Ischemic Stroke Diagnosis Market
  • 4.4.1: APAC Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others
• 4.5: ROW Acute Ischemic Stroke Diagnosis Market
  • 4.5.1: ROW Acute Ischemic Stroke Diagnosis Market by Diagnostic Type: Computed Tomography, Magnetic Resonance Imaging, Carotid Ultrasound, Cerebral Angiography, Electrocardiography, Echocardiography, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acute Ischemic Stroke Diagnosis Market by Diagnostic Type
  • 6.1.2: Growth Opportunities for the Global Acute Ischemic Stroke Diagnosis Market by Region
• 6.2: Emerging Trends in the Global Acute Ischemic Stroke Diagnosis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acute Ischemic Stroke Diagnosis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acute Ischemic Stroke Diagnosis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Fujifilm Holdings
• 7.2: Samsung Electronics
• 7.3: GE Healthcare
• 7.4: Nihon Kohden
• 7.5: Canon Medical Systems
• 7.6: Koninklijke Philips NV
• 7.7: Siemens Healthineers
• 7.8: Mindray Medical International
• 7.9: Nanavati Super Speciality Hospital
• 7.10: Hoffmann-La Roche